2021-01-12,   《HKEx》- 09966 ALPHAMAB-B - VOLUNTARY ANNOUNCEMENT - ABSTRACTS ON CLINICAL DATA FROM PHASE II CLINICAL STUDY OF KN046 IN PATIENTS WITH ADVANCED NSCLC AND PRELIMINARY RESULTS OF KN046 IN PATIENTS WITH RARE THORACIC TUMORS FOR PRESENTATION AT WCLC 2020 
2020-12-28," <Research Report>M Stanley's Latest Ratings, TPs on CN Drugmakers (Table)  "
2020-12-03,   《HKEx》- 09966 ALPHAMAB-B - Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2020 
2020-09-18, 6 CN Biotech Stocks Added to Southbound Trading Today 
2020-09-01,   《HKEx》- 09966 ALPHAMAB-B - VOLUNTARY ANNOUNCEMENT - INCLUSION OF THE SHARES OF THE COMPANY IN THE HONG KONG STOCK CONNECT LIST UNDER THE SHENZHEN-HONG KONG STOCK CONNECT 
2020-08-31,   《HKEx》- 09966 ALPHAMAB-B - WAIVER FROM STRICT COMPLIANCE WITH RULES 3.28 AND 8.17 OF THE LISTING RULES 
